Evidence map›Paper›PMID 41050757›Full record

ArticleFrontiers in cellular and infection microbiology2025

A highly divergent sample from a nearly extinct SARS-CoV-2 lineage in a patient with long-term COVID-19.

Elena Nabieva, Galya V Klink, Andrey B Komissarov, Stanislav V Zaitsev, Maria Sergeeva, Artem V Fadeev, Kseniya Komissarova, Anna Ivanova, Maria Pisareva, Kira Kudrya and 7 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Elena Nabieva *Russian Academy of Sciences, Moscow, Russia.
Galya V Klink *International Laboratory of Statistical and Computational Genomics, HSE University, Moscow, Russia.
Andrey B Komissarov *Smorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Stanislav V ZaitsevKaluga Regional Specialized Centre for Infectious Diseases and AIDS, Kaluga, Russia.
Maria SergeevaSmorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Artem V FadeevSmorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Kseniya KomissarovaSmorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Anna IvanovaSmorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Maria PisarevaSmorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Kira KudryaSmorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Daria DanilenkoSmorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Dmitry LioznovSmorodintsev Research Institute of Influenza, Saint-Petersburg, Russia.
Ryan HisnerUniversity of Cape Town, Rondebosch, South Africa.
Federico GueliIndependent Researcher, Como, Italy.
Thomas P PeacockDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Cornelius RoemerBiozentrum, University of Basel, Basel, Switzerland.
Georgii A BazykinRussian Academy of Sciences, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although COVID-19 is primarily an acute disease, there are cases of persistent infection, primarily in immunocompromised patients. It is hypothesized that at least some variants of concern (VOCs) have arisen in such persistent cases, with the virus "spilling over" into the general population after accumulating intra-host mutations. Additionally, a growing body of evidence hints at the gastrointestinal (GI) tract as a reservoir of long-term infection, at least in some cases. Results: We report the genomic analysis of a highly divergent SARS-CoV-2 sample obtained in October 2022 from an HIV+ patient with presumably long-term COVID-19 infection. Phylogenetic analysis indicates that the sample is characterized by a gain of 89 mutations since divergence from its nearest sequenced neighbor, which had been collected in September 2020 and belongs to the B.1.1 lineage, largely extinct by 2022. Of these mutations, 33 were nonsynonymous and occurred in the Spike protein. Of these, 17 are lineage-defining in some VOCs or are at sites where another mutation is lineage-defining in a VOC, and/or have been shown to be involved in antibody evasion, and/or have been detected in other cases of persistent COVID-19; these include some "usual suspects," such as Spike:L452R, E484Q, K417T, Y453F, and N460K. Molecular clock analysis indicates that mutations in this lineage accumulated at an increased rate compared with the ancestral B.1.1 strain. This increase is driven by the accumulation of non-synonymous mutations, with an average dN/dS value of 2.2, indicating strong positive selection during within-patient evolution. Additionally, the presence of mutations that are rare in the general population samples but common in samples from wastewater suggests that the virus had persisted for at least some time in the GI tract. Conclusions: Our analysis adds to the growing body of evidence that the evolution of SARS-CoV-2 in chronically infected patients can be a major source of novel epidemiologically important variants and points to the potential role of the GI tract in long-term infection.

Indexed as

COVID-19SARS-CoV-2Genome, ViralHIV InfectionsHumansMaleMutationPhylogenySpike Glycoprotein, CoronavirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2gastrointestinal COVID-19immunosuppressed hostintrahost evolutionintrapatient evolution of SARS-CoV-2persistent COVID-19

Identifiers

PMID41050757
PMCPMC12491319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.